Coffin, Phillip O.

Bupropion and naltrexone in methamphetamine use disorder

Trivedi, M. H., Walker, R., Ling, W., dela Cruz, A., Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., et al. (2021) · New England Journal of Medicine

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 281

Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections

Martin, W. J., Coffin, P. O., Attias, E., Balinsky, M., Tsou, K., & Walker, J. M. (1999) · Brain Research

Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments

Cited by 164

Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial

Coffin, P. O., Santos, G.-M., Hern, J., Vittinghoff, E., Walker, J. E., Matheson, T., Santos, D., Colfax, G., & Batki, S. L. (2020) · JAMA Psychiatry

Substance Abuse Treatment and OutcomesHIV, Drug Use, Sexual Risk

Cited by 139

Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: a pilot randomized controlled trial.

Coffin, P. O., Santos, G.-M., Matheson, T., Behar, E., Rowe, C., Rubin, T., Silvis, J., & Vittinghoff, E. (2017) · PLoS ONE

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 44

Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015

Rowe, C., Wheeler, E., Stephen Jones, T., Yeh, C., & Coffin, P. O. (2019) · Journal of Urban Health

Opioid Use Disorder TreatmentHIV, Drug Use, Sexual Risk

Cited by 28